Shared molecular mechanisms between type 2 diabetes and thyroid cancer: integrated bioinformatics insights for prognostic biomarker discovery
Endocrine Connections · 01.10.2025 · 14 (10)
DOI: 10.1530/ec-25-0181 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine Connections, online erschienen am 18.09.2025. Verfasst von Jiahui Qi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Aging, Key Laboratory of Alzheimer's Disease of Zhejiang Province, Wenzhou Medical University, Wenzhou, Zhejiang, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Thyroid cancer (TC) is a prevalent endocrine malignancy with rising global incidence, particularly among women. Emerging evidence suggests a significant association between type 2 diabetes mellitus (T2D) and TC, potentially mediated by hyperinsulinemia, insulin resistance, and chronic inflammation. However, the molecular mechanisms linking these diseases remain poorly understood.
Methods
We integrated transcriptomic datasets from the Gene Expression Omnibus (GEO) database (GSE33630, GSE35570, GSE60542 for TC; GSE86468 for T2D) to identify shared differentially expressed genes (DEGs). Functional enrichment, protein–protein interaction networks, and Cox regression analyses were employed to elucidate pathways and prognostic biomarkers.
Results
We identified 28 shared DEGs between TC and T2D, with CD44, TGFBI, RUNX2, and GJA1 as key hub genes. Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis highlighted pathways involving cell adhesion, extracellular matrix remodeling, and NF-κB signaling. A risk model incorporating seven genes (e.g., PRDM1 [protective] and ZFPM2 [risk]) stratified TC patients into high- and low-risk groups with distinct survival outcomes (P = 0.017).
Conclusion
T2D and TC exhibit overlapping genetic dysregulation, particularly in pathways governing metabolic reprogramming and tumor microenvironment crosstalk. Notably, PRDM1 and ZFPM2 may serve as therapeutic targets for TC in patients with concurrent diabetes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Aging, Key Laboratory of Alzheimer's Disease of Zhejiang Province, Wenzhou Medical University, Wenzhou, Zhejiang, China.
- Department of Thyroid Surgery, National Key Clinical Specialty (General Surgery), The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
- Department of Child Healthcare, The Third Clinical Institute Affiliated to Wenzhou Medical University, Wenzhou, Zhejiang, China.
- Department of Emergency Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
- Department of Metebolic Surgery, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
ORCID-Profile: Yue Wang
Zitieren
APA
Qi, J., Chen, C., Zhu, F., Chen, C., & Wang, Y. (2025). Shared molecular mechanisms between type 2 diabetes and thyroid cancer: integrated bioinformatics insights for prognostic biomarker discovery. Endocrine Connections, 14(10). https://doi.org/10.1530/ec-25-0181
Vancouver
Qi J, Chen C, Zhu F, Chen C, Wang Y. Shared molecular mechanisms between type 2 diabetes and thyroid cancer: integrated bioinformatics insights for prognostic biomarker discovery. Endocrine Connections. 2025;14(10). doi:10.1530/ec-25-0181
BibTeX
@article{Qi2025,
author = {Qi, Jiahui and Chen, Chuanzhi and Zhu, Feng and Chen, Chuankai and Wang, Yue},
title = {Shared molecular mechanisms between type 2 diabetes and thyroid cancer: integrated bioinformatics insights for prognostic biomarker discovery},
journal = {Endocrine Connections},
year = {2025},
volume = {14},
number = {10},
doi = {10.1530/ec-25-0181}
}
EUVIMED